MedTrace Logo

The Efficacy of Omega-3 Fatty Acids in Maintaining Optimal Mental Health in Elderly People

NCT00124852 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 302

Last updated 2011-01-12

No results posted yet for this study

Summary

The efficacy of EPA-DHA supplementation will be assessed in a randomized placebo-controlled trial with cognitive decline and early signs of depression as primary outcome measures.

Conditions

Interventions

BEHAVIORAL

n-3 Fatty Acid Supplementation

Sponsors & Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

    lead OTHER

Principal Investigators

  • Lisette de Groot, Dr Ir · Project leader

  • Marianne Geleijnse, Dr · Project leader

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2006-12-31
Completion
2007-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00124852 on ClinicalTrials.gov